IMMUGO Trademark

Trademark Overview

On Thursday, October 28, 2021, a trademark application was filed for IMMUGO with the United States Patent and Trademark Office. The USPTO has given the IMMUGO trademark a serial number of 97096672. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, December 16, 2025. This trademark is owned by Fresenius Kabi Deutschland GmbH. The IMMUGO trademark is filed in the Medical Instrument Products category with the following description:

Injection device for pharmaceutical preparations for human use and not for use in association with blood products
immugo

General Information

Serial Number97096672
Word MarkIMMUGO
Filing DateThursday, October 28, 2021
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, December 16, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 16, 2025

Trademark Statements

Pseudo MarkIMMUNE GO
Goods and ServicesInjection device for pharmaceutical preparations for human use and not for use in association with blood products

Classification Information

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateTuesday, November 9, 2021
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameFresenius Kabi Deutschland GmbH
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressBad Homburg 61352
DE
Party NameFresenius Kabi Deutschland GmbH
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressBad Homburg 61352
DE

Trademark Events

Event DateEvent Description
Monday, November 1, 2021NEW APPLICATION ENTERED
Tuesday, November 9, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, July 5, 2022ASSIGNED TO EXAMINER
Friday, July 8, 2022SUSPENSION LETTER WRITTEN
Friday, July 8, 2022LETTER OF SUSPENSION E-MAILED
Friday, July 8, 2022NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, August 11, 2022TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Thursday, August 11, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, August 11, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, August 24, 2022SUSPENSION LETTER WRITTEN
Wednesday, August 24, 2022LETTER OF SUSPENSION E-MAILED
Wednesday, August 24, 2022NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, March 29, 2023SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Monday, April 3, 2023REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Monday, December 18, 2023SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Wednesday, December 27, 2023REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Thursday, December 12, 2024SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Friday, December 13, 2024REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Friday, June 13, 2025NON-FINAL ACTION WRITTEN
Friday, June 13, 2025NON-FINAL ACTION E-MAILED
Friday, June 13, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, September 8, 2025APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Monday, September 8, 2025APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Wednesday, October 22, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, October 22, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, October 22, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, November 20, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 10, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 16, 2025PUBLISHED FOR OPPOSITION
Tuesday, December 16, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Related Keywords

immugo association blood products human preparations device pharmaceutical injection